Cargando…

The Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy

The article by Wilson et al., published in the February 2021 issue, reported the prognostic value of circulating tumor DNA (ctDNA) sequencing in head and neck squamous cell carcinoma (HNSCC), noting TP53 as the most altered and concordant gene in ctDNA and tDNA. This Letter to the Editor further con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Chao, Zhou, Xuanchen, Han, Jie, Yue, Zhiyong, Li, Butuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256032/ https://www.ncbi.nlm.nih.gov/pubmed/35536754 http://dx.doi.org/10.1093/oncolo/oyac087

Ejemplares similares

Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma
por: Zhou, Xuanchen, et al.
Publicado: (2020)

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
por: Omura, Go, et al.
Publicado: (2017)

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2021)

Exosomal microRNAs Targeting TP53 Gene as Promising Prognostic Markers for Head and Neck Squamous Cell Carcinoma
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2022)

In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma
por: Burcher, Kimberly M, et al.
Publicado: (2022)

TP53-Associated Ion Channel Genes Serve as Prognostic Predictor and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
por: Cho, Yoon Ah, et al.
Publicado: (2016)

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019)

Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer
por: Caponio, Vito Carlo Alberto, et al.
Publicado: (2020)

Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma
por: Matsuda, Shinichi, et al.
Publicado: (2020)

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma
por: Shi, Congyu, et al.
Publicado: (2021)

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2023)

Prognostic significance of TP53 alterations in breast carcinoma.
por: Andersen, T. I., et al.
Publicado: (1993)

p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
por: Peltonen, Jenni K, et al.
Publicado: (2010)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer
por: Mitra, Sanga, et al.
Publicado: (2014)

Ricolinostat enhances adavosertib-induced mitotic catastrophe in TP53-mutated head and neck squamous cell carcinoma cells
por: Miyake, Keitaro, et al.
Publicado: (2022)

The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer
por: Lin, Jiaying, et al.
Publicado: (2017)

Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation
por: Ashman, J N E, et al.
Publicado: (2003)

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study
por: Peltonen, Jenni K, et al.
Publicado: (2011)

Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients
por: Kampel, Liyona, et al.
Publicado: (2023)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Predictive value of epigenetic alterations in head and neck squamous cell carcinoma
por: Koffler, Jennifer, et al.
Publicado: (2014)

p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
por: Ganly, I, et al.
Publicado: (2000)

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
por: Bossi, Paolo, et al.
Publicado: (2016)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

Genome-Wide Analysis of Head and Neck Squamous Cell Carcinomas Reveals HPV, TP53, Smoking and Alcohol-Related Allele-Based Acquired Uniparental Disomy Genomic Alterations()
por: Tuna, Musaffe, et al.
Publicado: (2019)

TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
por: Klinakis, Apostolos, et al.
Publicado: (2020)

Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas
por: Dequanter, D, et al.
Publicado: (2015)

Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck
por: Boucek, Jan, et al.
Publicado: (2010)

PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma
por: Gong, Siming, et al.
Publicado: (2023)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

The prognostic value of MicroRNAs associated with fatty acid metabolism in head and neck squamous cell carcinoma
por: Wang, Xiaojing, et al.
Publicado: (2022)

Immunohistochemical over expression of p53 in head and neck Squamous cell carcinoma: clinical and prognostic significance
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Head and Neck Squamous Cell Carcinoma()()
por: Xu, Qiaoshi, et al.
Publicado: (2016)

The prognostic value of lymph node ratio in survival of head-and-neck squamous cell carcinoma
por: Eshraghi Samani, Reza, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bs2153mg1cq46d5i6pie1qranl